YWBCRI–Medanta

A South Asian hub at Medanta — The Medicity, expanding the Institute’s reach into populations and biological contexts that remain underrepresented in early-disease research.

The Young Women’s Breast Cancer Research Institute–Medanta (YWBCRI-Medanta) is part of the Young Women’s Breast Cancer Research Institute (YWBCRI), a global scientific effort supporting the Breast Cancer in Young Women Foundation. This location is part of the expanding international YWBCRI network, which is dedicated to investigating the initial biological changes that influence breast cancer risk, progression, and outcomes in younger women.

The institute contributes to YWBCRI’s broader aim of advancing breast cancer research by shifting focus from clinically confirmed cases to early biological processes that influence risk, transformation, progression, and eventual clinical outcomes in young women.

YWBCRI-Medanta’s scientific efforts focus on identifying and characterizing novel pathway-centered endpoints that could drive breast cells to become metabolically hyperactive. They also investigate immune, hormonal, metabolic, and molecular changes that may occur before the disease becomes clinically detectable. Additionally, the institute studies microinvasive and early breast lesions, such as ductal carcinoma in situ, to better understand biological transition states, persistence, transformation, and early clinical risk.

The institute aims to develop measurable systemic and tissue-based signatures of early risk. These include circulating, metabolic, molecular, and pathological biomarkers that could guide future efforts in early detection, risk assessment, prevention, and timely intervention.

The YWBCRI-Medanta site will be essential for confirming findings from other YWBCRI locations by using biomaterials derived from Indian breast tissue, including samples from normal mammoplasty procedures.

As part of the YWBCRI network, YWBCRI-Medanta contributes to the Institute’s integrated scientific programs, including:

• Determinants of Hypermetabolic Activity and its Downstream Zonal Impact on Breast Biology
• Biology of Microinvasive Ductal Carcinoma In Situ
• Detection of Early Systemic Risk Signals

Through collaboration with Medanta faculty, clinicians, researchers, and the broader YWBCRI network, YWBCRI-Medanta aims to apply its clinical excellence and scholarly rigor to accelerate research focused on breast cancer in young women.

Together, the YWBCRI centers form a coordinated international research network dedicated to understanding early disease biology, identifying risk before breast cancer becomes established or advanced, and creating new opportunities for prevention, earlier detection, and improved outcomes for young women.